NCT04543708 is a NA clinical trial of Incision drainage in Tonsillar Abscess, sponsored by University Hospital, Geneva.

Who is sponsoring NCT04543708?

NCT04543708 is sponsored by University Hospital, Geneva.

What drugs are being tested in NCT04543708?

Interventions in NCT04543708: Incision drainage, Tonsillectomy.

What condition does NCT04543708 study?

NCT04543708 studies Tonsillar Abscess.

Is NCT04543708 still recruiting?

NCT04543708 is currently status unknown. Last updated 7 April 2023.

Last reviewed 2023-04-07 · How we verify

NCT04543708

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Surgical Treatment of Tonsillar Abscess

Status unknown NA Last updated 7 April 2023

What this trial tests

NA trial testing Incision drainage in Tonsillar Abscess in 150 participants. Status unknown.

Timeline

1 October 2020

Primary endpoint
31 December 2023

31 May 2024

Quick facts

Lead sponsor	University Hospital, Geneva
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	150
Start date	1 October 2020
Primary completion	31 December 2023
Estimated completion	31 May 2024
Sites	1 location across Switzerland

Drugs / interventions tested

Incision drainage
Tonsillectomy

Conditions studied

Tonsillar Abscess — all drugs for Tonsillar Abscess →

Sponsor

University Hospital, Geneva

Who can join

18 and older, any sex, with Tonsillar Abscess. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The diagnosis and treatment of tonsillar abscess are very physician-dependent, as sufficient prospective medical literature is lacking to choose the most efficient regimen. The proposed study aims to assess the therapeutic efficacy of tonsillectomy compared to drainage under local anesthesia. This is a prospective, randomized clinical trial in adults in a tertiary care center in Geneva (Switzerland).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A randomized clinical trial of peritonsillar abscess treatment comparing drainage and tonsillectomy.
Voruz F, Revol R, Mermod M, Senn P, et al · · 2025 · PMID 41192203 · DOI 10.1016/j.amjoto.2025.104745

Verify or expand the search:

Other University Hospital, Geneva trials

Trials by the same sponsor.

NCT07506356 — Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors · recruiting
NCT07267624 — EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study) · NA · not yet recruiting
NCT06710210 — Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventi · NA · not yet recruiting
NCT07173348 — Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea · NA · not yet recruiting
NCT07129655 — Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Ch · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04543708 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Geneva
Last refreshed: 7 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04543708.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing